111 related articles for article (PubMed ID: 12581894)
1. Establishment of a new human cell line (EN) with TP53 mutation derived from endometrial carcinoma.
Isaka K; Nishi H; Sagawa Y; Nakada T; Osakabe Y; Serizawa H; Ebihara Y; Takayama M
Cancer Genet Cytogenet; 2003 Feb; 141(1):20-5. PubMed ID: 12581894
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new human cell line (EJ) derived from endometrial carcinoma.
Isaka K; Nishi H; Nakada T; Osakabe Y; Hokamura M; Serizawa H; Ebihara Y; Takayama M
Hum Cell; 2002 Dec; 15(4):200-6. PubMed ID: 12889855
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a cell line (CUMC-3) derived from a human squamous carcinoma of the uterine cervix.
Kim JW; Cho YH; Lyu MS; Lee CG; Jung JK; Kim SJ; Namkoong SE
Gynecol Oncol; 1995 Apr; 57(1):47-60. PubMed ID: 7705700
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a highly tumorigenic human diploid endometrial cancer cell line.
Kim JW; Lee CG; Choi SK; Kim JH; Kim TE; Lee JM; Rha JG; Namkoong SE
Cancer Genet Cytogenet; 1997 Nov; 99(1):1-10. PubMed ID: 9352788
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and characterization of the new cell line (EI) from a human endometrial adenocarcinoma].
Yudate T; Isaka K; Okabe K; Takayama M
Hum Cell; 1995 Mar; 8(1):43-8. PubMed ID: 7669752
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of a human endometrial adenocarcinoma established in vivo and in vitro.
Karlsson L; Leser G; Ryd W; Delle U; Köpf I; Horvath G
In Vivo; 1996; 10(4):421-8. PubMed ID: 8839789
[TBL] [Abstract][Full Text] [Related]
7. CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix.
Kim JW; Lee CG; Cho YH; Kim JH; Kim SJ; Kim HK; Park TC; Song SK; Namkoong SE
Gynecol Oncol; 1996 Aug; 62(2):230-40. PubMed ID: 8751555
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of a cisplatin-resistant new human endometrial adenocarcinoma cell line, Sawano cells].
Satoh T; Nishida M; Miyazaki Y; Sugita M; Arai Y; Oki A; Kono K; Tsunoda H; Kasahara K; Kubo T
Hum Cell; 1995 Jun; 8(2):67-72. PubMed ID: 8555123
[TBL] [Abstract][Full Text] [Related]
9. Establishment of new epithelial carcinoma cell lines by blocking monolayer formation.
Hackenberg R; Hawighorst T; Hild F; Schulz KD
J Cancer Res Clin Oncol; 1997; 123(11-12):669-73. PubMed ID: 9620227
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a new cell line derived from a human primary breast carcinoma.
Wang CS; Goulet F; Lavoie J; Drouin R; Auger F; Champetier S; Germain L; Têtu B
Cancer Genet Cytogenet; 2000 Jul; 120(1):58-72. PubMed ID: 10913678
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a cell line from a neuroendocrine carcinoma of the endometrium and an invasion model.
Yoshida Y; Kamitani N; Sasaki H; Kotsuji F
Anticancer Res; 1998; 18(3A):1569-77. PubMed ID: 9673372
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma.
Kakuno Y; Yamada T; Mori H; Narabayashi I
Hum Cell; 2008 May; 21(2):46-55. PubMed ID: 18397474
[TBL] [Abstract][Full Text] [Related]
13. Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro.
Dery MC; Van Themsche C; Provencher D; Mes-Masson AM; Asselin E
Reprod Biol Endocrinol; 2007 Sep; 5():38. PubMed ID: 17894888
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of a new human endometrial adenocarcinoma cell line, Watanabe cells, containing estrogen receptor].
Satoh T; Nishida M; Oki A; Tsunoda H; Kasahara K; Kubo T
Hum Cell; 1995 Dec; 8(4):195-201. PubMed ID: 8721091
[TBL] [Abstract][Full Text] [Related]
15. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a human uterine endometrial undifferentiated carcinoma cell line, TMG-L.
Hasegawa K; Suzuki M; Ishikawa K; Yasue A; Kato R; Nakamura A; Kuroki J; Udagawa Y
Hum Cell; 2003 Mar; 16(1):31-8. PubMed ID: 12971623
[TBL] [Abstract][Full Text] [Related]
17. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.
Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW
Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a poorly differentiated lethal human endometrial carcinoma cell line (NOU-1) with karyotype 46,XX.
Faruqi SA; Satyaswaroop PG; LiVolsi VA; Deger RB; Noumoff JS
Cancer Genet Cytogenet; 2002 Oct; 138(1):44-9. PubMed ID: 12419584
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas.
Saffari B; Bernstein L; Hong DC; Sullivan-Halley J; Runnebaum IB; Grill HJ; Jones LA; El-Naggar A; Press MF
Int J Gynecol Cancer; 2005; 15(5):952-63. PubMed ID: 16174251
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential.
Sato N; Mizumoto K; Beppu K; Maehara N; Kusumoto M; Nabae T; Morisaki T; Katano M; Tanaka M
Cancer Lett; 2000 Jul; 155(2):153-61. PubMed ID: 10822130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
